McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Wiesner RH |
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. |
1998 |
Transplant. Proc. |
pmid:9636565
|
Van Buren D et al. |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). |
1998 |
Transplant. Proc. |
pmid:9636566
|
Jain A et al. |
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9636567
|
Zervos XA et al. |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636568
|
Millis JM et al. |
Successful use of tacrolimus for initial rejection episodes after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636569
|
Platz KP et al. |
FK506 for primary and rescue therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636570
|
Taibi A et al. |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. |
1998 |
Transplant. Proc. |
pmid:9636571
|
Cai TH et al. |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636572
|
Ringe B et al. |
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. |
1998 |
Transplant. Proc. |
pmid:9636573
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results. |
1998 |
Transplant. Proc. |
pmid:9636575
|
Bilbao I et al. |
Experience with neoral cyclosporine through the oral route in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636580
|
Langrehr JM et al. |
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636583
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Klupp J et al. |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636585
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Liu WT et al. |
In vitro generation of tacrolimus metabolites and their detection in whole blood. |
1998 |
Transplant. Proc. |
pmid:9636590
|
Bekersky I et al. |
Bioequivalence of a new strength tacrolimus capsule under development. |
1998 |
Transplant. Proc. |
pmid:9636591
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|